| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | ||
|---|---|---|---|---|---|---|
OPERATING ACTIVITIES: | ||||||
Net loss | ||||||
-28,884 | -25,991 | 0 | 0 | 0 | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
694 | 684 | 0 | 0 | 0 | ||
Share-based compensation expense | ||||||
2,432 | 1,982 | 0 | 0 | 0 | ||
Loss from equity-method investment | ||||||
0 | - | - | - | 0 | ||
Other non-cash expenses | ||||||
0 | - | - | - | 0 | ||
Changes in operating assets and liabilities | ||||||
Accounts receivable | ||||||
-2,106 | -2,302 | 0 | 0 | 0 | ||
Prepaid expense and other assets | ||||||
1,008 | 120 | 0 | 0 | 0 | ||
Accounts payable | ||||||
-706 | 3,155 | 0 | 0 | 0 | ||
Accrued liabilities | ||||||
5,481 | 1,675 | 0 | 0 | 0 | ||
Deferred revenue | ||||||
6,158 | 8,970 | 0 | 0 | 0 | ||
Net cash used in operating activities | ||||||
-12,892 | -6,445 | 0 | 0 | 0 | ||
INVESTING ACTIVITIES: | ||||||
Acquisition of property and equipment | ||||||
882 | 818 | 0 | 0 | 0 | ||
Net cash used in investing activities | ||||||
-882 | -818 | 0 | 0 | 0 | ||
FINANCING ACTIVITIES: | ||||||
Proceeds from exercise of stock options | ||||||
0 | - | - | - | - | ||
Net cash provided by financing activities | ||||||
0 | - | - | - | - | ||
NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | ||||||
28,251 | 34,644 | 0 | 0 | 0 | ||
Supplemental disclosure of cash flow information | ||||||
Cash paid for interest | ||||||
752 | 691 | 0 | 0 | 0 | ||
Non-cash investing activities | ||||||
Right-of-use asset obtained in exchange for lease liabilities | ||||||
674 | 5,868 | 0 | 0 | 0 | ||
Purchase of property and equipment in accounts payable | ||||||
367 | 240 | 0 | 0 | 0 | ||